| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $234K | — |
| R&D Expense | $24.6M | -19.4% |
| SG&A Expense | $17.4M | -15.1% |
| Operating Income | -$41.6M | +17.8% |
| Interest Expense | $887K | +1037.2% |
| Net Income | -$41.2M | +17.3% |
| EPS (Basic) | -$1.28 | +27.7% |
| EPS (Diluted) | -$1.28 | +27.7% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.8M | -68.7% |
| Accounts Receivable | $3K | -84.2% |
| Current Assets | $57.7M | -14.3% |
| Total Assets | $68.1M | -27.2% |
| Current Liabilities | $6.8M | -40.7% |
| Stockholders' Equity | $30.0M | -47.4% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.5M | -18.1% |
| Capital Expenditures | $280K | -24.9% |
| Investing Cash Flow | $11.8M | +262.2% |
| Financing Cash Flow | $7.5M | -87.8% |
| Free Cash Flow | -$36.8M | -17.6% |